Singapore plans drug price cuts, easier PIs

23 April 2001

Singapore's Health Minister, Lim Hng Kiang, has set up a new statutorycommittee whose task will be to propose ways in which the country's drug prices can be reduced and patients' access to the most advanced treatments improved.

The panel, which is expected to make its recommendations by the end of the year, will also be charged with finding methods of enabling consumers to make more informed choices about their medications, through improvements in the availabilityand provision of comparative information on efficacy and cost, reports the Straits Times Weekly newspaper.

The government will also be taking steps to facilitate parallel importing of cheaper drugs, and to extend to the private sector a new bulk drug-purchasing collaboration between public health care services in the eastern and western halves of the island.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight